Company intelligence / Profile preview

Millennium Magnetic Technologies

Ridgefield, Connecticut, United Stateszoominfo.com ↗

Ownership: Private
Development stage: Commercial

Overview

Millennium Magnetic Technologies has developed and commercialized the MentScan platform—a functional MRI-based screening tool capable of detecting early brain changes indicative of preclinical Alzheimer’s disease. The technology can also objectively document pain using neuroimaging. Their methods have been used in legal cases to provide evidence for pain claims.

Therapeutic areas: OtherNeurology
Modalities: Functional MRI-based diagnostics
Industry: Medical Imaging

Beyond the preview

Go deeper on Millennium Magnetic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Millennium Magnetic Technologies.

Explore the full profile